Amaero International Limited (ASX:3DA) Expands Production Capabilities
Amaero International Limited secures a third EIGA atomizer, bolstering production for advanced manufacturing, as part of a strategic investment of A$71 million.
Amaero International Limited secures a third EIGA atomizer, bolstering production for advanced manufacturing, as part of a strategic investment of A$71 million.
Orthocell submits its FDA application for Remplir™, targeting the US nerve repair market, with clearance expected by April 2025.
Imugene Limited (ASX:IMU) secures $11 million R&D tax refund to advance its immuno-oncology therapies.
EBR Systems, Inc. announces a scheduled FDA Pre-Approval Inspection for its wireless cardiac pacing device, a pivotal step in regulatory progress.
Deep Yellow Limited announces an 18% increase in Ore Reserves at the Tumas Project, estimating a 30-year mine life.
Clarity Pharmaceuticals (ASX:CU6) unveils a novel radiopharmaceutical, SAR-bisFAP, enhancing cancer diagnosis and treatment potential.
Perpetual Resources Ltd (ASX: PEC) reports final assays from Isabella showing ultra high-grade spodumene up to 6.8% Li2O.
Green Technology Metals (ASX:GT1) reports high-grade lithium discoveries at the Junior Lithium Project in Ontario, confirming significant potential.
Skin Elements Limited (ASX:SKN) has requested a trading halt pending significant announcements regarding a court application and capital raising.
Rhythm Biosciences (ASX:RHY) reports key milestones achieved, including the launch of ColoSTAT® Beta release candidate kits and significant financial updates.